
As Associate Director, Search & Evaluation, you help Novo find and evaluate the next generation of treatments. You will act as our scientific eyes and ears in the region, scouting novel pipeline assets and enabling technologies across our therapy areas, then assessing how they fit our pipeline. Your judgement shapes which opportunities we pursue, helping bring promising science closer to people living with serious chronic diseases.
You will drive the technical side of business development, from strategy through to due diligence, while representing Novo externally across the region.
You will join Global Business Development within Research & Development, where colleagues explore scientific ideas and advance them towards clinical testing.
Your closest partners will be colleagues across Global Business Development, alongside scientific, medical and commercial teams inside Novo. Externally, you will build relationships with venture capital, biotech companies and other large-cap pharma across the region. By bringing these perspectives together with clarity and pace, you help move the right opportunities forward.
You will work at the forefront of scientific partnering, with the space to build a broad external network and shape decisions that influence our future pipeline. You will be trusted to take ownership, make your voice heard and grow your expertise through cross-functional and cross-value-chain collaboration. The work moves at pace, combining curiosity, collaboration
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html